Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Cash from Investing Activities: 2009-2024

Historic Cash from Investing Activities for OptimizeRx (OPRX) over the last 16 years, with FY2024 value amounting to -$450000.0.

  • OptimizeRx's Cash from Investing Activities rose 8913.04% to -$10000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$222000.0, marking a year-over-year increase of 5403.73%. This contributed to the annual value of -$450000.0 for FY2024, which is 9822.39% up from last year.
  • OptimizeRx's Cash from Investing Activities amounted to -$450000.0 in FY2024, which was up 9822.39% from -$25.3 million recorded in FY2023.
  • In the past 5 years, OptimizeRx's Cash from Investing Activities registered a high of -$124725.0 during FY2020, and its lowest value of -$58.2 million during FY2022.
  • Over the past 5 years, OptimizeRx's median Cash from Investing Activities value was -$485999.0 (recorded in 2021), while the average stood at -$16.9 million.
  • In the last 5 years, OptimizeRx's Cash from Investing Activities surged by 9882.14% in 2020 and then plummeted by 1187047.44% in 2022.
  • Over the past 5 years, OptimizeRx's Cash from Investing Activities (Annual) stood at -$124725.0 in 2020, then tumbled by 289.66% to -$485999.0 in 2021, then tumbled by 11870.47% to -$58.2 million in 2022, then surged by 56.45% to -$25.3 million in 2023, then skyrocketed by 98.22% to -$450000.0 in 2024.
  • Its last three reported values are -$450000.0 in FY2024, -$25.3 million for FY2023, and -$58.2 million during FY2022.